Business Model:
Revenue: $0
Employees: 0-0
Address:
City:
State:
Zip:
Country:
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
5/2004 | Cambridge Broadband Networks | Series C | 0 |
2/2002 | alfabet | Series B | 5.2M |
4/2001 | Develogen AG | Series B | 0 |
9/2002 | CoreOptics | Series B | 0 |
8/2004 | Enanta Pharmaceuticals | Venture Round | 20M |
6/2001 | Cambridge Broadband Networks | Series B | 16.5M |
7/2003 | Ardana Bioscience | Series B | 32.4M |
8/1998 | Intercell | Series A | - |
1/2001 | EpiCept Corporation | Series C | 0 |
10/2004 | Bluebird Bio | Venture Round | 12M |
1/2004 | Enanta Pharmaceuticals | Venture Round | 0 |
7/2002 | Enanta Pharmaceuticals | Series E | 18.3M |
3/2001 | B-there.com | Venture Round | 6.5M |
4/1999 | Tantau Software | Series A | 11M |
9/2002 | Cardion | Venture Round | 11.3M |
3/2001 | Nanostream Inc. | Series B | - |
6/2003 | Nanostream Inc. | Series C | 22M |
3/2001 | Pharmasset | Series C | 7.4M |
8/2004 | Pharmasset | Series D | 40M |
7/2003 | Intercell | Series C | 50M |
9/2000 | Vividence | Series D | 34M |
6/2000 | Tantau Software | Series B | 0 |
1/2003 | ClearCube | Series D | 20M |
3/2001 | iolon, inc. | Series B | 53M |
7/2000 | Enanta Pharmaceuticals | Series B | 20M |
9/2004 | Coley Pharmaceutical Group | Series G | 25.2M |
8/1999 | Coley Pharmaceutical Group | Series B | 12.9M |
12/2001 | Amnis | Venture Round | 8.8M |
2/2002 | Coley Pharmaceutical Group | Series E | 7M |
5/2000 | PolyTrax Information Technology | Series B | 0 |
11/2008 | Helomics | Venture Round | 43M |
7/2000 | Impress Software Solutions | Venture Round | 19.3M |
1/1999 | Enanta Pharmaceuticals | Series A | 5.1M |
2/2001 | Zeptosens | Series B | 0 |
12/2000 | DIREVO Industrial Biotechnology | Series A | 7.8M |
1/2001 | CoreOptics | Series A | 15M |
6/2000 | Cambridge Broadband Networks | Series A | 5M |
10/2004 | iTAC Software | Series C | 0 |
8/2000 | NanoGram | Series A | 0 |
7/2000 | Streaming21 | Series B | 0 |
2/2001 | Talia | Series C | 4M |
5/2004 | Addex Therapeutics | Series B | 0 |
4/2004 | Evotec Neurosciences | Series A | 30.5M |
12/2002 | DIREVO Industrial Biotechnology | Series B | 0 |
1/1999 | Ingenium Pharmaceuticals AG | Series A | - |
5/2000 | HepaVec AG | Series A | 0 |
8/2003 | Coley Pharmaceutical Group | Series F | 30M |
1/2000 | EpiCept Corporation | Series B | 4.6M |
9/2003 | Helomics | Series C | 15M |
11/2001 | Jerini | Series B | 17.6M |
6/2004 | Jerini | Series B | 38M |
11/2003 | CoreOptics | Series C | 0 |
8/2005 | Streaming21 | Venture Round | - |
6/2005 | Revolt Technology | Series A | 8.5M |
1/2004 | SelectX Pharmaceuticals Inc. | Series B | 8M |
6/2002 | Confluent Surgical | Series C | 20M |
7/2002 | Addex Therapeutics | Series A | 9.9M |
4/2003 | Sirna Therapeutics | Venture Round | 48M |
8/2001 | IC Mechanics | Series A | 5M |
4/1997 | EpiCept Corporation | Series A | 4.7M |
11/2008 | Helomics | Venture Round | 0 |
8/2005 | Streaming21 | Venture Round | - |
6/2005 | Revolt Technology | Series A | 0 |
10/2004 | Bluebird Bio | Venture Round | 0 |
10/2004 | iTAC Software | Series C | 0 |
9/2004 | Coley Pharmaceutical Group | Series G | 0 |
8/2004 | Enanta Pharmaceuticals | Venture Round | 0 |
8/2004 | Pharmasset | Series D | 0 |
6/2004 | Jerini | Series B | 0 |
5/2004 | Addex Therapeutics | Series B | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|